News | October 06, 2009

New PET Application Helps Improve Detection of CAD

October 6, 2009 – Siemens Healthcare announced the availability of syngo Dynamic PET with myocardial blood flow, a new cardiac imaging software application for the industry-leading Biograph PET/CT scanners that may have significant impact on the diagnosis of patients with advanced coronary artery disease (CAD) and specifically, with those patients with multivessel disease, or those who are asymptomatic.

This new application is on display at the Siemens booth 207, at the American Society for Nuclear Cardiology Scientific Session in Minneapolis.

According to the “Heart Disease and Stroke Statistics 2009 Update,” published by the American Heart Association (AHA), one of every five deaths each year is attributed to CAD, making it the largest killer in the United States. At least 50 percent of those who die suddenly of CAD had no previous symptoms, and it has been reported that those with documented CAD have five to seven times the risk of having a myocardial infarction or dying than the general population.

Within this large CAD patient population, published clinical literature has estimated that 5 percent to 10 percent of CAD patients have balanced vessel disease, and up to 8 percent are asymptomatic at-risk patients. It is especially within this high-risk group that the new imaging application offers additional diagnostic value. syngo Dynamic PET with myocardial blood flow is the first and only FDA-cleared software from a major vendor to offer a new method for quantitatively evaluating the extent of ischemia via high-performance PET/CT imaging and advanced applications.

Quantifying the extent of the disease is important in the patient evaluation. In some circumstances, a conventional myocardial perfusion study may suggest that the perfusion is within normal ranges, but in fact, it may not be. Specific quantification of perfusion levels in each vessel can help improve the identification of multi-vessel disease and may mitigate the risk for misdiagnoses or underestimated risk factors.

The new syngo Dynamic PET with myocardial blood flow application enables the more definitive measurement of myocardial blood flow during PET perfusion studies as compared to regular myocardial perfusion studies* (data on file). Combined with the advanced 3D PET performance of the Biograph family of PET•CT scanners, conventional static perfusion and the dynamic perfusion required for myocardial blood flow is now possible with single-injection protocols for virtually all patients with no additional scan time or patient dose. A variety of information on syngo Dynamic PET with myocardial blood flow is available at the Siemens booth and on the company’s Web site. At www.siemens.com/mi, a variety of supporting information can be found, including clinical case presentations, a review of clinical literature, clinical primers, scientific whitepapers, and product demonstrations with real clinical data.

For more information: www.siemens.com/healthcare

Related Content

PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
News | PET-CT | February 06, 2019
Technological advancements in positron emission tomography/computed tomography (PET/CT) offer both clinicians and pat
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...